Please enter the keywords you want to search for
Sansheng Pharmaceutical takes over 670 million yuan for sales of AstraZeneca diabetes products in China
News Search
Ranked among the top 50 global pharmaceutical companies in 2025, Luye Pharmaceutical releases its "full industry chain" strategy
Haizheng Pharmaceutical Irbesartan Tablets Obtained US FDA Approval
AstraZeneca submits marketing application for a new constipation drug linaclotide to CFDA
Liraglutide receives FDA risk reduction label for cardiovascular disease
Fosun (USA) spends US$18 million to purchase multiple Sandoz generic drug varieties
